157 related articles for article (PubMed ID: 35400000)
21. The relationship between osteoclastogenic and anti-osteoclastogenic pro-inflammatory cytokines differs in human osteoporotic and osteoarthritic bone tissues.
Zupan J; Komadina R; Marc J
J Biomed Sci; 2012 Mar; 19(1):28. PubMed ID: 22380539
[TBL] [Abstract][Full Text] [Related]
22. RANKL inhibition reduces lesional cellularity and Gα
de Castro LF; Whitlock JM; Michel Z; Pan K; Taylor J; Szymczuk V; Boyce B; Martin D; Kram V; Galisteo R; Melikov K; Chernomordik LV; Collins MT; Boyce AM
Bone Res; 2024 Feb; 12(1):10. PubMed ID: 38378678
[TBL] [Abstract][Full Text] [Related]
23. Effect of Zuoguiwan on osteoporosis in ovariectomized rats through RANKL/OPG pathway mediated by β2AR.
Liu F; Tan F; Tong W; Fan Q; Ye S; Lu S; Teng Z; Han M; Zhang M; Chai Y
Biomed Pharmacother; 2018 Jul; 103():1052-1060. PubMed ID: 29710663
[TBL] [Abstract][Full Text] [Related]
24. Osteosarcoma arising in fibrous dysplasia, confirmed by mutational analysis of GNAS gene.
Sugiura Y; Kanda H; Motoi N; Nomura K; Inamura K; Okada E; Matsumoto H; Shimoji T; Matsumoto S; Nakayama J; Takazawa Y; Ishikawa Y; Machinami R
Pathol Res Pract; 2018 Feb; 214(2):318-324. PubMed ID: 29268950
[TBL] [Abstract][Full Text] [Related]
25. Relationship Between RANK and RANKL Gene Polymorphisms with Osteoporosis in Rheumatoid Arthritis Patients.
Mohamed RH; Mohamed RH; El-Shahawy EE
Genet Test Mol Biomarkers; 2016 May; 20(5):249-54. PubMed ID: 26914636
[TBL] [Abstract][Full Text] [Related]
26. Changes in RANKL/OPG/RANK gene expression in peripheral mononuclear cells following treatment with estrogen or raloxifene.
Bashir A; Mak YT; Sankaralingam S; Cheung J; McGowan NW; Grigoriadis AE; Fogelman I; Hampson G
Steroids; 2005 Dec; 70(13):847-55. PubMed ID: 16005483
[TBL] [Abstract][Full Text] [Related]
27. Effects of the anti-receptor activator of nuclear factor kappa B ligand denusomab on beta thalassemia major-induced osteoporosis.
Yassin MA; Soliman AT; De Sanctis V; Abdelrahman MO; Aziz Bedair EM; AbdelGawad M
Indian J Endocrinol Metab; 2014 Jul; 18(4):546-51. PubMed ID: 25143915
[TBL] [Abstract][Full Text] [Related]
28. Berberine alleviates oxidative stress in rats with osteoporosis through receptor activator of NF-kB/receptor activator of NF-kB ligand/osteoprotegerin (RANK/RANKL/OPG) pathway.
He XF; Zhang L; Zhang CH; Zhao CR; Li H; Zhang LF; Tian GF; Guo MF; Dai Z; Sui FG
Bosn J Basic Med Sci; 2017 Nov; 17(4):295-301. PubMed ID: 29055350
[TBL] [Abstract][Full Text] [Related]
29. Expression and Distribution of Receptor Activator of Nuclear Factor Kappa B, Receptor Activator of Nuclear Factor Kappa B Ligand, and Osteoprotegerin in Periradicular Cysts.
Armada L; Marotta Pdos S; Pires FR; Siqueira JF
J Endod; 2015 Aug; 41(8):1281-7. PubMed ID: 25956608
[TBL] [Abstract][Full Text] [Related]
30. Gsalpha gene mutations in monostotic fibrous dysplasia of bone and fibrous dysplasia-like low-grade central osteosarcoma.
Pollandt K; Engels C; Kaiser E; Werner M; Delling G
Virchows Arch; 2001 Aug; 439(2):170-5. PubMed ID: 11561757
[TBL] [Abstract][Full Text] [Related]
31. Fibula allograft transplantation combined with locking plate for treatment of recurrent monostotic fibular fibrous dysplasia: A case report.
Xie LL; Yuan X; Zhu HX; Fu L; Pu D
World J Clin Cases; 2023 Nov; 11(33):8050-8057. PubMed ID: 38075580
[TBL] [Abstract][Full Text] [Related]
32. Fibrous Dysplasia of Proximal Femur: A Case Report of Treatment With Single-Stage Valgus Osteotomy With Dynamic Hip Screw and Fibular Strut Graft.
Vyas A; Godara A; Kumar N; Singhal S; Bhattacherjee D
Cureus; 2022 Jan; 14(1):e21496. PubMed ID: 35223273
[TBL] [Abstract][Full Text] [Related]
33. QiangGuYin Modulates the OPG/RANKL/RANK Pathway by Increasing Secretin Levels during Treatment of Primary Type I Osteoporosis.
Li X; Cui L; Chen W; Fang Y; Shen G; Li Z; Zhang B; Wu L
Evid Based Complement Alternat Med; 2021; 2021():7114139. PubMed ID: 34754319
[TBL] [Abstract][Full Text] [Related]
34. Conservative surgical management of simple monostotic fibrous dysplasia of the proximal femur in a 19-year-old basketballer: a case report.
Yung D; Kikuta K; Sekita T; Asano N; Nakayama R; Nakamura M; Matsumoto M
J Med Case Rep; 2018 Aug; 12(1):240. PubMed ID: 30165901
[TBL] [Abstract][Full Text] [Related]
35. Fibrous dysplasia of the maxillary bone secondary to sinus surgery in an elderly patient: A case report.
Park HJ; Geum SY; Yoo JH; Park JW; Shin SH; Ye MK
Ear Nose Throat J; 2022 Nov; ():1455613221139403. PubMed ID: 36357084
[TBL] [Abstract][Full Text] [Related]
36. Outward bulging of the right parietal bone in connection with fibrous dysplasia in an infant: a case report.
Al Kaissi A; Klaushofer K; Grill F
Cases J; 2008 Nov; 1(1):347. PubMed ID: 19025620
[TBL] [Abstract][Full Text] [Related]
37. Malignant transformation in monostotic fibrous dysplasia: clinical features, imaging features, outcomes in 10 patients, and review.
Qu N; Yao W; Cui X; Zhang H
Medicine (Baltimore); 2015 Jan; 94(3):e369. PubMed ID: 25621678
[TBL] [Abstract][Full Text] [Related]
38. Tea polysaccharide inhibits RANKL-induced osteoclastogenesis in RAW264.7 cells and ameliorates ovariectomy-induced osteoporosis in rats.
Xu H; Yin D; Liu T; Chen F; Chen Y; Wang X; Sheng J
Biomed Pharmacother; 2018 Jun; 102():539-548. PubMed ID: 29587240
[TBL] [Abstract][Full Text] [Related]
39. Denosumab and alendronate treatment in patients with back pain due to fresh osteoporotic vertebral fractures.
Tetsunaga T; Tetsunaga T; Nishida K; Tanaka M; Sugimoto Y; Takigawa T; Takei Y; Ozaki T
J Orthop Sci; 2017 Mar; 22(2):230-236. PubMed ID: 28087216
[TBL] [Abstract][Full Text] [Related]
40. Targeting receptor-activator of nuclear kappaB ligand in aneurysmal bone cysts: verification of target and therapeutic response.
Pelle DW; Ringler JW; Peacock JD; Kampfschulte K; Scholten DJ; Davis MM; Mitchell DS; Steensma MR
Transl Res; 2014 Aug; 164(2):139-48. PubMed ID: 24726460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
